Lucus Advisors LLC decreased its stake in Chemed Corp. (NYSE:CHE) by 32.4% during the second quarter, according to its most recent filing with the SEC. The firm owned 2,583 shares of the company’s stock after selling 1,239 shares during the period. Lucus Advisors LLC’s holdings in Chemed Corp. were worth $352,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of CHE. Norges Bank acquired a new position in shares of Chemed Corp. during the fourth quarter worth about $40,455,000. Los Angeles Capital Management & Equity Research Inc. boosted its position in shares of Chemed Corp. by 6.6% in the first quarter. Los Angeles Capital Management & Equity Research Inc. now owns 5,636 shares of the company’s stock worth $763,000 after buying an additional 350 shares in the last quarter. BlackRock Inc. boosted its position in shares of Chemed Corp. by 90.4% in the first quarter. BlackRock Inc. now owns 1,152 shares of the company’s stock worth $156,000 after buying an additional 547 shares in the last quarter. BlackRock Group LTD boosted its position in shares of Chemed Corp. by 7.2% in the first quarter. BlackRock Group LTD now owns 22,610 shares of the company’s stock worth $3,062,000 after buying an additional 1,514 shares in the last quarter. Finally, BlackRock Institutional Trust Company N.A. boosted its position in shares of Chemed Corp. by 0.4% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 431,220 shares of the company’s stock worth $58,409,000 after buying an additional 1,831 shares in the last quarter. 98.62% of the stock is currently owned by institutional investors and hedge funds.
Chemed Corp. (NYSE:CHE) traded down 2.28% during midday trading on Thursday, hitting $139.41. The stock had a trading volume of 62,473 shares. Chemed Corp. has a 52 week low of $124.77 and a 52 week high of $160.12. The stock’s 50 day moving average price is $136.85 and its 200-day moving average price is $135.73. The company has a market cap of $2.26 billion, a PE ratio of 22.11 and a beta of 1.14.
Chemed Corp. (NYSE:CHE) last posted its quarterly earnings data on Monday, July 25th. The company reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.08. Chemed Corp. had a net margin of 6.93% and a return on equity of 24.12%. The company had revenue of $290 million for the quarter, compared to the consensus estimate of $393.50 million. During the same quarter in the previous year, the firm posted $1.71 EPS. The business’s revenue was up 2.2% compared to the same quarter last year. Equities research analysts predict that Chemed Corp. will post $7.25 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 2nd. Stockholders of record on Monday, August 15th were issued a dividend of $0.26 per share. This is an increase from Chemed Corp.’s previous quarterly dividend of $0.24. The ex-dividend date was Thursday, August 11th. This represents a $1.04 annualized dividend and a dividend yield of 0.75%. Chemed Corp.’s payout ratio is presently 16.51%.
A number of equities analysts have issued reports on the stock. RBC Capital Markets reissued a “sector perform” rating and issued a $162.00 target price (up previously from $136.00) on shares of Chemed Corp. in a report on Wednesday, July 27th. Royal Bank Of Canada raised their target price on shares of Chemed Corp. from $136.00 to $162.00 and gave the stock a “sector perform” rating in a report on Wednesday, July 27th. Zacks Investment Research raised shares of Chemed Corp. from a “hold” rating to a “buy” rating and set a $167.00 target price on the stock in a report on Thursday, July 28th. Oppenheimer Holdings Inc. reissued an “outperform” rating and issued a $155.00 target price on shares of Chemed Corp. in a report on Tuesday. Finally, JMP Securities reissued a “hold” rating on shares of Chemed Corp. in a report on Sunday, September 4th. Four research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $161.50.
In other news, VP Arthur V. Tucker, Jr. sold 3,089 shares of the business’s stock in a transaction dated Thursday, August 4th. The shares were sold at an average price of $143.88, for a total transaction of $444,445.32. Following the transaction, the vice president now owns 3,234 shares in the company, valued at approximately $465,307.92. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Arthur V. Tucker, Jr. sold 4,500 shares of the business’s stock in a transaction dated Friday, August 5th. The stock was sold at an average price of $144.28, for a total transaction of $649,260.00. Following the transaction, the vice president now owns 7,734 shares in the company, valued at approximately $1,115,861.52. The disclosure for this sale can be found here. Insiders own 5.32% of the company’s stock.
About Chemed Corp.
Chemed Corporation operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corp. (NYSE:CHE).
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.